Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P41
Within normal range
vs 3Y Ago
-0.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -23.19% |
| Q3 2025 | 4.14% |
| Q2 2025 | 10.57% |
| Q1 2025 | -25.56% |
| Q4 2024 | -13.01% |
| Q3 2024 | -36.02% |
| Q2 2024 | 30.14% |
| Q1 2024 | -124.35% |
| Q4 2023 | 30.82% |
| Q3 2023 | 9.06% |
| Q2 2023 | -18.62% |
| Q1 2023 | -60.69% |
| Q4 2022 | 31.80% |
| Q3 2022 | -38.49% |
| Q2 2022 | 39.08% |
| Q1 2022 | -80.77% |
| Q4 2021 | -4.14% |
| Q3 2021 | 41.60% |
| Q2 2021 | -150.91% |
| Q1 2021 | 8.20% |
| Q4 2020 | -68.75% |
| Q3 2020 | -62.40% |
| Q2 2020 | -0.32% |
| Q1 2020 | -81.56% |
| Q4 2019 | -34.88% |
| Q3 2019 | -22.87% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2017 | -69.00% |
| Q3 2017 | 234.57% |
| Q2 2017 | -45.64% |
| Q1 2017 | 451.85% |
| Q4 2016 | -91.87% |
| Q3 2016 | 163.49% |
| Q2 2016 | -34.03% |
| Q1 2016 | 191.83% |
| Q4 2015 | -164.40% |
| Q3 2015 | 850.00% |
| Q2 2015 | 161.82% |
| Q1 2015 | 83.73% |